Drug profile · INN
darunavir + cobicistat + emtricitabine + tenofovir alafenamide
SYMTUZA
- Patents linked
- 0
- News articles
- 0
Quick answer
darunavir + cobicistat + emtricitabine + tenofovir alafenamide (SYMTUZA) is an FDA-listed pharmaceutical active ingredient. Associated with Janssen-Cilag Pty Ltd.
Key facts
INN darunavir + cobicistat + emtricitabine + tenofovir alafenamide
Brand SYMTUZA
Originator Janssen-Cilag Pty Ltd
Frequently asked questions
What is darunavir + cobicistat + emtricitabine + tenofovir alafenamide?
darunavir + cobicistat + emtricitabine + tenofovir alafenamide (SYMTUZA) is an FDA-listed pharmaceutical active ingredient. Associated with Janssen-Cilag Pty Ltd.
What is the brand name for darunavir + cobicistat + emtricitabine + tenofovir alafenamide?
SYMTUZA is a marketed brand name for darunavir + cobicistat + emtricitabine + tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.